Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Targeted alpha particle immunotherapy for myeloid leukemia.

Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR, Ballangrud AM, Hamacher KA, Ma D, Humm JL, Brechbiel MW, Molinet R, Scheinberg DA.

Blood. 2002 Aug 15;100(4):1233-9.

2.

Antibody therapy for residual disease in acute myelogenous leukemia.

Jurcic JG.

Crit Rev Oncol Hematol. 2001 Apr;38(1):37-45. Review.

PMID:
11255080
3.

Antibody-targeted therapy for myeloid leukemia.

Appelbaum FR.

Semin Hematol. 1999 Oct;36(4 Suppl 6):2-8. Review.

PMID:
10530710
4.

Treatment of acute leukaemias with monoclonal antibodies: current status and future prospects.

Leone G, Sica S, Voso MT, Rutella S, Pagano L.

Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):33-52. Review.

PMID:
16529548
5.

Antibody-based treatment of acute myeloid leukaemia.

Mulford DA, Jurcic JG.

Expert Opin Biol Ther. 2004 Jan;4(1):95-105. Review.

PMID:
14680472
6.

Targeted alpha-particle immunotherapy for acute myeloid leukemia.

Jurcic JG, Rosenblat TL.

Am Soc Clin Oncol Educ Book. 2014:e126-31. doi: 10.14694/EdBook_AM.2014.34.e126. Review.

7.

Antibody therapy in acute myeloid leukemia: current status and future directions.

Burke JM, Jurcic JG.

Clin Lymphoma. 2002 Mar;2 Suppl 1:S12-8. Review.

PMID:
11970765
8.

Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates.

Sievers EL.

Cancer Chemother Pharmacol. 2000;46 Suppl:S18-22. Review.

PMID:
10950142
9.

The promise of targeted {alpha}-particle therapy.

Mulford DA, Scheinberg DA, Jurcic JG.

J Nucl Med. 2005 Jan;46 Suppl 1:199S-204S. Review.

10.

Immunotherapy for acute myeloid leukemia.

Jurcic JG.

Curr Oncol Rep. 2005 Sep;7(5):339-46. Review.

PMID:
16091194
11.

Antibody therapy of acute myelogenous leukemia.

Jurcic JG.

Cancer Biother Radiopharm. 2000 Aug;15(4):319-26. Review.

PMID:
11041016
12.

Radioimmunoconjugates in acute leukemia treatment: the future is radiant.

Kotzerke J, Bunjes D, Scheinberg DA.

Bone Marrow Transplant. 2005 Dec;36(12):1021-6. Review.

PMID:
16247432
14.
15.

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.

Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E.

Cancer. 1999 Feb 1;85(3):608-15. Review.

PMID:
10091734
16.

Radioimmunotherapy for acute leukemia.

Burke JM, Jurcic JG, Scheinberg DA.

Cancer Control. 2002 Mar-Apr;9(2):106-13. Review.

PMID:
11965231
17.

ABCs of radioisotopes used for radioimmunotherapy: alpha- and beta-emitters.

Waldmann T.

Leuk Lymphoma. 2003;44 Suppl 3:S107-13. Review.

PMID:
15202533
18.

Antibody immunotherapy for leukemia.

Jurcic JG.

Curr Oncol Rep. 2000 Mar;2(2):114-22. Review.

PMID:
11122832
19.

Radioimmunotherapy with alpha-particle emitting radionuclides.

Zalutsky MR, Pozzi OR.

Q J Nucl Med Mol Imaging. 2004 Dec;48(4):289-96. Review.

20.

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.

Morgenstern A, Bruchertseifer F, Apostolidis C.

Curr Radiopharm. 2012 Jul;5(3):221-7. Review.

PMID:
22642390

Supplemental Content

Support Center